期刊名称：NEUROTOXICOLOGY AND TERATOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Neurotoxicology and Teratology
|
Neurotoxicology and Teratology presents original reports of systemic studies in the areas of adult neurotoxicology and developmental neurotoxicology in which the primary emphasis and theoretical context are on the nervous system and/or behavior. The Journal publishes original, peer-reviewed studies that cover the developmental and adult neurotoxicity of pesticides, drugs of abuse, pharmaceuticals, solvents, heavy metals, organometals, general industrial-use compounds, marine and plant toxins, atmospheric reaction compounds, and physical agents such as radiation and noise. |
 |
Neurotoxicology and Teratology also features Brief Communications that concisely describe a new method, technique, or apparatus and experimental results. Invited Reviews and Open Peer Commentary series provide a timely update on selected aspects of a scientific field undergoing rapid change or on areas that present special methodological or interpretive problems.
Abstracting / Indexing
- BIOSIS
- Current Contents/Life Sciences
- EMBASE
- ETOH
- Elsevier BIOBASE
|
- Index Medicus
- MEDLARS
- Medline
- Science Citation Index
|
Instructions to Authors
Neurotoxicology and Teratology publishes only peer-reviewed original reports of systematic studies in the areas of neurotoxicology and developmental neurotoxicology in which the primary emphasis and theoretical context are on the nervous system and/or behavior. Brief Communications describe a new method, technique, or apparatus and results of experiments which can be reported briefly with limited figures and tables. Invited Reviews provide a timely update on selected aspects of a scientific field undergoing rapid change or that present special methodological or interpretive problems. Full-length review articles are also published. A limited number of relevant theoretical articles, results of symposia, and reviews with open peer commentaries will also be published. Articles will be published in English. All article types are peer-reviewed. Submitted papers may not be simultaneously under consideration for publication elsewhere.
All manuscripts should be sent to the Editor-in-Chief for review and processing: Charles V. Vorhees, Ph.D., Division of Developmental Biology, Children's Hospital Research Foundation, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, Tel: (513)636-8622, Fax: (513)636-3912; E-mail: charles.vorhees@chmcc.org. Authors may suggest the appropriate section of the journal in which they wish their paper reviewed. Authors are encouraged to nominate potential reviews (preferably 4-6 names). Authors must provide the complete name and address of suggested reviewers and include office telephone, FAX number, and E-mail address, if available.
STYLE OF MANUSCRIPT
General Form. (1) Manuscripts should be submitted in triplicate and should be typewritten, double spaced with wide margins on good quality paper. If a word processor is utilized to prepare the manuscript, a letter quality printer must be used and computer generated illustrations must be of the same quality as professional line drawings or they will not be accepted. (2) The title page should contain: title of paper; author(s); laboratory or institution of origin with city, state, zip code, and country; complete address for mailing proofs, including telephone and FAX numbers, and e-mail address, if available. (3) References, footnotes, and legends for illustrations should be typed on separate sheets, double spaced. (4) Illustrations (unmounted photographs) should be identified on the reverse with figure number and author(s) name; when necessary the top should be clearly marked. (5) Each table should be typed on a separate sheet and double spaced. (6) All dimensions and measurements must be specified in the metric system. Standard nomenclature, abbreviations and symbols, as specified by Royal Society Conference of Editors. Metrication in Scientific Journals, Am Scient 56 (1968) 159-164, should be used throughout. (7) Italics should not be used for the purpose of emphasis.
Title. The title should not be longer than 85 characters, including spaces between words.
Length of Paper. The editors insist upon clear, concise statement of facts and conclusions. Fragmentation of material into numerous short reports is discouraged. There is no page or word limitation on manuscript length.
Abstract. Each paper submitted must be accompanied by an abstract, which should be around 200 words and must be suitable for use by abstracting services. A list of 3-6 words or short phrases suitable for indexing terms should be typed at the bottom of the abstract page accompanying the manuscript. These terms will be printed with the paper at the end of the abstract.
Headings. All headings should be numbered according to the following examples:
1. Introduction
2. Methods
3. Results
3.1 Maternal variables
3.1.1. Pregnancy rate
3.1.2. Maternal weight gain
3.2. Fetal variables
4. Discussion
Drugs. Proprietary (trademarked) names should be capitalized. The chemical name should precede the trade, popular name, or abbreviation of a drug the first time it occurs.
Footnotes. Footnotes that connect authors with their affiliations should be provided as superscript lower-case letters (a,b,c, etc.) and should be given in alphabetical order. If senior author is not to receive reprint requests, a footnote should be given to designate to whom requests should be sent. Text footnotes should not be used; the material should be incorporated into the text. Table footnotes: see Table (b)
References. Literature cited should be prepared according to the Numbered/Alphabetized style of the CBE. References should be cited by number, in brackets, within the text (only one reference to a number) and listed in alphabetical order (double spaced) on a separate sheet at the end of the manuscript. Do not recite names of authors within the text. Journal citations in the reference list should contain the following: (a) initials and surnames of all authors (initials precede surname); (b) title of article; (c) journal title abbreviated as listed in the List of Journals Indexed in Index Medicus; (d) volume, year, and inclusive pages. Example:
[1]R.R. Holson, B. Pearce, Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species, Neurotoxicol Teratol 14 (1992) 221-228.
Book references should be in the following order: author, title, publisher, city of publication, year, and pages. Examples:
[1]R.E. Kirk, Experimental Design: Procedures for the Behavioral Sciences, Third Edition, Brooks/Cole Publishing Company, Pacific Grove, CA, 1995.
[2]M.G. Paule, J. Adams, Interspecies comparison of the evaluation of cognitive developmental effects of neurotoxicants in primates, in: L.W. Chang (Ed.), Principles of Neurotoxicology, Marcel Dekker, Inc., New York, 1994, pp. 713-731.
Electronic submission. Authors should submit an electronic copy of their paper with the final version of the manuscript. The electronic copy should match the hardcopy exactly. Always keep a backup copy of the electronic file for reference and safety. Full details of electronic submission and formats can be obtained from http://authors.elsevier.com.
Submission on Disk after Acceptance for Publication. Elsevier Science now publishes all manuscripts using electronic production methods and strongly encourages submission on disk. Please send the electronic files of your article along with the hardcopy of the accepted version. To ensure fast and easy processing of your submission, please adhere to the following guidelines:
1. Save text and graphics on separate disks.
2. Label all disks with your name, a short version of the article title, the journal to be published in, and the filenames. Please also include details of the software and platform (PC, Mac, UNIX, etc) used to create your files.
3. Ensure that the files on the disk match the hardcopy exactly. In cases of a discrepancy, the hardcopy version will be used as the definitive version.
Illustrations. (a) Prepare for use in a single column width whenever possible. (b) All drawings for reduction to a given size should be drawn and lettered to the same scale. (c) All illustrations should be referred to as figures and numbered in Arabic numerals. (d) Lettering should be done in India ink or other suitable material and must be proportionate to the size of the illustrations if it is to be legible after reduction. Lettering should be sized so that its smallest elements (subscripts or superscripts) will be readable when reduced. (e) When possible all lettering should be within the framework of the illustration; likewise the key to symbols should be on the face of the chart. The following standard symbols should be used as they are easily available to the printer: O
   +. (f) Actual magnification of all photomicrographs should be given. Dimension scale should be indicated. (g) Sharply contrasting unmounted photographs of figures on glossy paper are required. (h) Illustrations should be submitted in black and white unless color reproduction is requested. Color prints should be submitted in actual size and authors will be responsible for the additional costs.
Tables. (a) Each table should have a brief heading; explanatory matter should be in footnotes, not as part of the title. (b) Table footnotes should be indicated in the body of the table in order of their appearance with superscript, lower-case letters (a,b,c etc.). Footnotes pertaining to statistical information should be indicated with asterisks (*p , 0.01, **p , 0.001, etc.). (c) Tables must not duplicate material in text or illustrations. (d) Vertical rules should be omitted. (e) Short or abbreviated column heads should be used. (f) Statistical measures of variation, SD, SE, etc., should be identified. (g) Analysis of Variance tables should not be submitted but significant F's should be incorporated where appropriate within the text. The appropriate form for reporting F value is: F(11, 20)= 3.05, p   0.01.
Formulas and Equations. Structural chemical formulas, process flowdiagrams, and complicated mathematical expressions should be kept to a minimum. usually chemical formulas and flow-diagrams should be drawn in India ink for reproduction as line cuts. All subscripts, superscripts, Greek letters, and unusual characters must be clearly identified.
Anesthesia. In describing surgical procedures on animals, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided that anesthesia of suitable grade and duration was employed.
Proofs. Corrections to the proofs must be restricted to printer's errors only. Other than these, any other alterations will be charged to the author.
Reprints. Each author will receive with the galley proofs a reprint order form which must be completed and returned. Corresponding author will receive 50 complimentary reprints.
Copyright. Publications are copyrighted for the protection of the authors and the publisher. A Transfer of Copyright Agreement will be sent to the author who submits the manuscript. The form must be completed and returned to the publisher before the article can be published.
Editorial Board
Editor-in-Chief:
Charles Vorhees, Division of Developmental Biology, Children's Hospital Research Foundation, Cincinnati, OH, USA; Email: charles.vorhees@chmcc.org
Section Editors:
Neurochemistry:
J.P. O'Callaghan, Health Effects Laboratory Division, Center for Disease Control and Prevention, NIOSH, Morgantown, WV, USA; Email: jdo5@cdc.gov
Behavioral Toxicology:
D.C. Rice, U.S. Environmental Protection Agency, Washington, DC, USA; Email: rice.deborah@epa.gov
Epidemiology:
D.C. Bellinger, Children's Hospital and Harvard Medical School, Neuroepidemiology Unit, 300 Longwood Avenue, Boston, MA 02115, USA; Tel: (617)355 6565, Fax: (617)734 6527, Email: david.bellinger@tch.havard.edu
Developmental Neurotoxicology:
C. Vorhees, Division of Developmental Biology, Children's Hospital Research Foundation, Cincinnati, OH, USA; Email: charles.vorhees@chmcc.org
Reviews:
E. D. Levin, Duke University Medical Center, Durham, NC, USA Email: edlevin@duke.edu
Editorial Advisory Board:
J. Adams, University of Massachusetts, Boston, MA, USA
E. Alleva, Istituto Superiore Di Sanita, Roma, Italia
W.K. Anger, Oregon Health Sciences University, Portland, OR, USA
K.W.S. Ashwell, University of New South Wales,Kensington, Australia
S. Barron, University of Kentucky, Lexington, KY, USA
M.L. Billingsley, Pennsylvania State University, Hershey, PA, USA
B.J. Brockel, Kansas State University, Manhattan, KS, USA
J. Buelke-Sam, Greenfield, IN, USA
P.J. Bushnell, US Environmental Protection Agency, Research Triangle Park, NC, USA
P. Clausing, Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany
K.M. Crofton, US Environmental Protection Agency, Research Triangle Park, NC, USA
K.N. Dietrich, Cincinnati, OH, USA
D. Dow-Edwards, State University of New York, Brooklyn, NY, USA
D.A. Eckerman, University of North Carolina, Chapel Hill, USA
S. Ferguson, National Center for Toxicological Research/FDA, Jefferson, AR, USA
M. Golub, University of California, Davis, CA, USA
J.H. Hannigan, Wayne State University, Detroit, MI, USA
H.K. Hudnell, U.S. EPA, Research Triangle Park, NC, USA
R. Letz, Atlanta, GA, USA
L.D. Middaugh, Medical University of South Carolina, Charleston, SC, USA
D.B. Miller, National Institute for Occupational Safety and Health, Morgantown, WV, USA
J.C. Molina, Universidad Nacional de Cordoba, Cordoba, Argentina
R.E. Morgan, Malcomb, IL, USA
V.C. Moser, US Environment Protection Agency, Research Triangle Park, NC, USA
H. Needleman, UMPC Health System, Pittsburgh, PA, USA
B.K. Nelson, Cincinnati, OH, USA
M.C. Newland, Auburn University, Auburn, AL, USA
H. Ohmori, Misasakai Corporation for Social Welfare, Hiroshima, Japan
G.E. Olsen, Oregon Health Sciences Center School of Medicine, Portland, OR, USA
M.G. Paule, National Center for Toxicological Research, Jefferson, AR, USA
I. Pessah, University of California, Davis, CA, USA
W.J. Pizzi, Northeastern Illinois University, Chicago, IL, USA
G.A. Richardson, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
P.M. Rodier, University of Rochester, Rochester, NY, USA
S.L. Schantz, University of Illinois, Urbana, IL, USA
M.E. Stanton, University of Delaware, Newark, DE, USA
P. Stewart, State University of New York at Oswego, Oswego, NY, USA
B.J. Strupp, Cornell University, Ithaca, NY, USA
J.D. Thomas, San Diego State University, San Diego, CA, USA
W.P. Weisenburger, Pfizer Central Research, Gorton, CT, USA
|
